MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$396K
Net Income
-$36,700K
Net Profit Margin
-9267.68%
EPS
-$0.97
Unit: Thousand (K) dollars
Revenue Breakdown
Nonrelated Party
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenues
396
193
1,163
2,172
Research and development
32,489
26,251
27,003
25,544
General and administrative
8,195
8,869
7,337
6,528
Total operating expenses
40,684
35,120
34,340
32,072
Loss from operations
-40,288
-34,927
-33,177
-29,900
Interest and investment income
3,658
3,403
3,791
-
Gain on investment in former related party
227
32
-
-
Loss on currency exchange, net
-2
-30
-22
-48
Gain on investment in related party
-
-
-
307
Interest income, other
-
-
-
4,445
Loss on investment in related party
-
-
5
-
Other (expense)/income
-360
-107
-98
22
Total other income
3,523
3,298
3,666
4,726
Net loss
-36,765
-31,629
-29,511
-25,174
Unrealized gain on marketable securities
65
-172
164
718
Total other comprehensive income
65
-172
164
718
Total comprehensive loss
-36,700
-31,801
-29,347
-24,456
Basic EPS
-0.97
-0.88
-0.82
-0.74
Diluted EPS
-0.97
-0.88
-0.82
-0.74
Basic Average Shares
37,794,088
35,822,308
35,790,700
34,236,728
Diluted Average Shares
37,794,088
35,822,308
35,790,700
34,236,728
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Unrealized gain on
marketable securities
$65K
(-90.95%↓ Y/Y)
Total comprehensive
loss
-$36,700K
(-50.07%↓ Y/Y)
Total other
comprehensive income
$65K
(-90.95%↓ Y/Y)
Interest and investment
income
$3,658K
Gain on investment in
former related party
$227K
Net loss
-$36,765K
(-46.04%↓ Y/Y)
Total other income
$3,523K
(-25.45%↓ Y/Y)
Nonrelated Party
$396K
Other
(expense)/income
-$360K
(-1736.36%↓ Y/Y)
Loss on currency
exchange, net
-$2K
(95.83%↑ Y/Y)
Loss from operations
-$40,288K
(-34.74%↓ Y/Y)
Total revenues
$396K
(-81.77%↓ Y/Y)
Total operating
expenses
$40,684K
(26.85%↑ Y/Y)
Research and development
$32,489K
(27.19%↑ Y/Y)
General and
administrative
$8,195K
(25.54%↑ Y/Y)
Buy us a coffee
Dianthus Therapeutics, Inc. DE (DNTH)
Dianthus Therapeutics, Inc. DE (DNTH)